Show
Sort by
-
- Journal Article
- A1
- open access
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up
-
- Journal Article
- A1
- open access
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
-
Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology
-
Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps : data from the SYNAPSE study
(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB126-AB126 -
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper
-
- Journal Article
- A1
- open access
Allergic respiratory disease care in the COVID-19 era : a EUFOREA statement
-
- Journal Article
- A1
- open access
Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA
-
Much ado about biologicals : highlights of the Master Class on Biologicals, Prague, 2018
-
ERS/EAACI statement on severe exacerbations in asthma in adults : facts, priorities and key research questions
-
- Journal Article
- A1
- open access
EUFOREA consensus on biologics for CRSwNP with or without asthma